Immunosuppression and experimental tuberculosis. II. The effects of immunosuppressive agents and antilymphocyte serum on the organ dissemination of mycobacteria and on the development of specific delayed hypersensitivity.
D000818:Animals; D000942:Antigens, Bacterial; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001379:Azathioprine / Q000494:pharmacology; D001380:Azauridine / Q000494:pharmacology; D002464:Cell Migration Inhibition; D002701:Chloramphenicol / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D005260:Female; D006968:Hypersensitivity, Delayed / Q000175:diagnosis; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007668:Kidney / Q000382:microbiology; D008099:Liver / Q000382:microbiology; D008168:Lung / Q000382:microbiology; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000276:immunology / Q000302:isolation & purification*; D013154:Spleen / Q000382:microbiology; D014376:Tuberculosis / Q000175:diagnosis / Q000276:immunology*; D014774:Virulence
D000942:Antigens, Bacterial; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D002701:Chloramphenicol; D001380:Azauridine; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate